HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+9.13%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.44B
AUM Growth
+$2.44B
(-9.4%)
Cap. Flow
-$376M
Cap. Flow
% of AUM
-15.43%
Top 10 Holdings %
Top 10 Hldgs %
44.28%
Holding
112
New
29
Increased
17
Reduced
20
Closed
38
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$106M |
| 2 |
CVS Health
CVS
|
$106M |
| 3 |
Bristol-Myers Squibb
BMY
|
$98.5M |
| 4 |
Thermo Fisher Scientific
TMO
|
$92.3M |
| 5 |
Natera
NTRA
|
$89.7M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$111M |
| 2 |
Incyte
INCY
|
$93M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$79.2M |
| 4 |
AbbVie
ABBV
|
$78.9M |
| 5 |
IQVIA
IQV
|
$77.6M |
Sector Composition
| 1 | Healthcare | 90.66% |
| 2 | Consumer Discretionary | 4.55% |
| 3 | Real Estate | 2.63% |
| 4 | Financials | 1.91% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Welltower
WELL
$112B
| $36.1M | 1.44% |
434,590
-492,450
| -53% | -$40.9M |
|
27
HCA Healthcare
HCA
$95B
| $35.1M | 1.4% |
169,710
-245,280
| -59% | -$50.7M |
|
28
McKesson
MCK
$86B
| $30.7M | 1.23% |
160,760
-312,570
| -66% | -$59.8M |
|
29
Cencora
COR
$57.2B
| $30.3M | 1.21% |
264,340
-318,950
| -55% | -$36.5M |
|
30
Syndax Pharmaceuticals
SNDX
$1.39B
| $30.1M | 1.2% |
1,751,342
+379,862
| +28% | +$6.52M |
|
31
Halozyme
HALO
$8.58B
| $29.5M | 1.18% |
649,052
-96,553
| -13% | -$4.38M |
|
32
Ventas
VTR
$30.9B
| $28M | 1.12% |
489,640
-660,220
| -57% | -$37.7M |
|
33
Tenet Healthcare
THC
$16.4B
| $25.2M | 1.01% |
+376,180
| New | +$25.2M |
|
|
34
Vertex Pharmaceuticals
VRTX
$103B
| $23.8M | 0.95% |
117,960
-548,500
| -82% | -$111M |
|
35
DexCom
DXCM
$29.1B
| $21.7M | 0.87% |
50,890
-91,220
| -64% | -$39M |
|
|
LGV
36
DELISTED
Longview Acquisition Corp. II
LGV
| $20.9M | 0.84% |
+2,135,900
| New | +$20.9M |
|
|
AFMD
37
DELISTED
Affimed
AFMD
| $20.6M | 0.82% |
2,422,964
+835,020
| +53% | +$7.1M |
|
38
Idexx Laboratories
IDXX
$51.2B
| $18.9M | 0.75% |
29,900
+11,490
| +62% | +$7.26M |
|
39
Cytokinetics
CYTK
$5.94B
| $14.8M | 0.59% |
749,310
+286,810
| +62% | +$5.68M |
|
|
DCPH
40
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $14.1M | 0.57% |
+386,190
| New | +$14.1M |
|
|
RACB
41
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $13.4M | 0.54% |
1,324,800
+324,800
| +32% | +$3.29M |
|
|
ARYD
42
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $13.3M | 0.53% |
1,238,881
+79,521
| +7% | +$852K |
|
43
LivaNova
LIVN
$3.11B
| $10.5M | 0.42% |
+125,000
| New | +$10.5M |
|
|
MSAC
44
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $7.18M | 0.29% |
+744,000
| New | +$7.18M |
|
45
Ironwood Pharmaceuticals
IRWD
$213M
| $6.73M | 0.27% |
522,712
-213,489
| -29% | -$2.75M |
|
46
RAPT Therapeutics
RAPT
$196M
| $6.36M | 0.25% |
+200,000
| New | +$6.36M |
|
47
GH Research
GHRS
$864M
| $5.43M | 0.22% |
+250,000
| New | +$5.43M |
|
|
IMA
48
ImageneBio, Inc. Common Stock
IMA
$149M
| $5.3M | 0.21% |
377,551
+36,339
| +11% | +$510K |
|
|
OHPA
49
DELISTED
Orion Acquisition Corp. Class A common stock
OHPA
| $5.29M | 0.21% |
+547,598
| New | +$5.29M |
|
|
EQRX
50
DELISTED
EQRx, Inc. Common Stock
EQRX
| $5.16M | 0.21% |
+500,000
| New | +$5.16M |
|